A5102801028- Chronic Myeloid Leukemia Treatments
- IgG4-Related and Inflammatory Diseases
- Medical Imaging and Pathology Studies
- Urinary and Genital Oncology Studies
- Soft tissue tumor case studies
- Bladder and Urothelial Cancer Treatments
- Peripheral Nerve Disorders
- CAR-T cell therapy research
- Pain Management and Treatment
- Acute Lymphoblastic Leukemia research
- Shoulder Injury and Treatment
- Renal cell carcinoma treatment
Augusta University Health
2022-2024
University Hospital of Geneva
2015
The effect of prior inotuzumab ozogamicin (InO) treatment on brexucabtagene autoleucel (brexu-cel) outcomes remains unclear in adults with acute lymphoblastic leukemia (ALL). We conducted a retrospective multicenter analysis 189 patients relapsed/refractory ALL treated brexu-cel. Over half the received InO before brexu-cel (InO exposed). InO-exposed were more heavily pretreated (P = .02) and frequently had active marrow disease apheresis .03). Response rate toxicity profile after comparable...
Urothelial carcinomas are the fourth most common tumors in men. Upper tract urinary (UTUCs) uncommon and represent only 5-10% of urothelial carcinomas.(1) Metastatic testicular cancers rare primary tumor sources prostate, lung, gastrointestinal tract. We report first case metastasis 2 years after initial curative surgery for a high-grade UTUC, all other reported cases weren't proceed by surgery.(3).